Binding drugs on two position of M2 proton channel and its mutants

IFMBE Proceedings

Volumn 40 IFMBE, Issue , 2013, Pages 384-390

  Nguyen, T Hieu ^a   Hoang, Dzung ^a   Le, Ly ^b  

^a UNIVERSITY OF NATURAL SCIENCES   (Viet Nam)

^b INTERNATIONAL UNIVERSITY   (Viet Nam)

Author keywords

binding energy; drug resistance; inhibitors; M2 channel; mutants

Indexed keywords

AMANTADINE; BINDING DRUGS; DRUG RESISTANCE; INFLUENZA VIRUS; INTERMOLECULAR ENERGY; M2 CHANNEL; MOLECULAR DOCKING; MUTANTS; NMR STRUCTURES; PROTON CHANNELS; RIMANTADINE; WILD TYPES;

BIOMEDICAL ENGINEERING; CORROSION INHIBITORS; DOCKING; PROTEINS; PROTONS; VIRUSES;

BINDING ENERGY;

EID: 84871542567     PISSN: 16800737     EISSN: None     Source Type: Conference Proceeding    
DOI: 10.1007/978-3-642-32183-2_93     Document Type: Conference Paper

References (18)

1. Helenius A (1992) Unpacking the incoming influenza virus. Cell 69:577-578.
2. Pinto LH, et al. (1997) A functionally defined model for the M2 proton channel of influenza A virus suggests a mechanism for its ion selectivity. Proc Natl Acad Sci USA 94:11301-11306.
3. Sakaguchi T, Tu Q, Pinto LH, Lamb RA (1997) The active oligomeric state of the minimalistic influenza virus M2 ion channel is a tetramer. Proc Natl Acad Sci USA 94:5000-5005.
4. Hay AJ, Wolstenholme AJ, Skehel JJ, Smith MH (1985) The molecular basis of the specific anti-influenza action of amantadine. EMBO J 4:3021-3024.
5. Schnell JR, Chou JJ (2008) Structure and mechanism of the M2 proton channel of influenza A virus. Nature 451: 591-595.
6. Du Q-S, Huang R-B, Wang Q-S, Chou K-C (2010) Designing Inhibitors of M2 Proton Channel against H1N1 Swine Influenza Virus. PloS ONE 5(2): e9388.
7. Stouffer AL, et al. (2008) Structural basis for the function and inhibition of an influenza virus proton channel. Nature 451:596-599.
8. Chen H, Wu Y, Voth GA (2007) Proton transport behavior through the influenza A M2 channel: Insights from molecular simulation. Biophys J 93:3470-3479.
9. Hu J, Fu R, Cross TA. (2007) The chemical and dynamical influence of the anti-viral drug amantadine on the M2 proton channel transmembrane domain. Biophys J 93:276-283.
10. Hu J, et al. (2006) Histidines, heart of the hydrogen ion channel from influenza A virus: Toward an understanding of conductance and proton selectivity. Proc Natl Acad Sci USA 103:6865-6870.
11. Matthew R. Rosenberg and Marco G. Casarotto (2010) Coexistence of two adamantane binding sites in the influenza A M2 ion channel. PNAS 107: 13866-13871.
12. Cady SD, et al. (2010) Structure of the amantadine binding site of influenza M2 proton channels in lipid bilayers. Nature 463:689-692.
13. Tataridis D, Fytas G, Kolocouris A, Fytas C, Kolocouris N, et al. (2007) Influence of an additional 2-amino substituent of the 1-aminoethyl pharmacophore group on the potency of rimantadine against influenza virus A. Bioorg Med Chem Lett 17: 692-696.
14. Pathumwadee Intharathep, et al. (2008) How amantadine and rimantadine inhibit proton transport in the M2 protein channel. Journal of Molecular Graphics and Modelling 27: 342-348.
15. Stamatiou G, Kolocouris A, Kolocouris N, Fytas G, Foscolos GB, et al. (2001) Novel 3-(2-Adamantyl)pyrrolidines with Potent Activity Against Influenza A Virus-Identification of Aminoadamantane Derivatives Bearing Two Pharmacophoric Amine Groups. Bioorg Med Chem Lett 11: 2137-2142.
16. Wei H, Wang CH, Du QS, Meng J, Chou KC (2009) Investigation into Adamantane-Based M2 Inhibitors with FB-QSAR. Medicinal Chemistry 5: 305-317.
17. Laohpongspaisan C, Rungrotmongkol T, Intharathep P, Malaisree M, Decha P, Aruksakunwong O, Sompornpisut P, Hannongbua S (2009) Why Amantadine Loses Its Function in Influenza M2 Mutants: MD Simulations. J Chem Inf Model 49: 847-52
18. Astrahan P, Kass I, Cooper MA, Arkin IT (2004) A novel method of resistance for influenza against a channel-blocking antiviral drug. Proteins 55: 251-7